Pear Therapeutics, Inc. (“Pear Therapeutics”), the leader in developing and commercializing software-based medicines, called prescription…
Arboretum_JDDecember 6, 2021
Convergent Dental, developer of Solea®, the world’s first laser to enable reliably anesthesia-free, pain-free dentistry,…
Arboretum_JDOctober 26, 2021
SonarMD continues to gain momentum in 2021 as the leading valuebased care coordination solution for…
Arboretum_JDOctober 14, 2021
Akadeum Life Sciences, Inc., today announced the closing of an oversubscribed $17.5 million Series B…
Arboretum_JDOctober 12, 2021
Delphinus Medical Technologies, Inc. today announced that the U.S. Food and Drug Administration (FDA) has…
Arboretum_JDOctober 12, 2021
Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management…
Arboretum_JDSeptember 15, 2021
Francis Medical, Inc., a privately-held medical device company developing an innovative and proprietary water vapor…
Arboretum_JDSeptember 15, 2021
RareCyte, Inc. (“RareCyte” or “the Company”) a Life Sciences company developing and manufacturing proprietary platforms…
Arboretum_JDSeptember 9, 2021
Arboretum Ventures, a leading healthcare venture capital firm based in Ann Arbor, Michigan, today announced…
Arboretum_JDAugust 11, 2021
